BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2926 related articles for article (PubMed ID: 22740491)

  • 1. Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire.
    Bazarganipour F; Ziaei S; Montazeri A; Faghihzadeh S; Frozanfard F
    Hum Reprod; 2012 Sep; 27(9):2729-36. PubMed ID: 22740491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ).
    Ou HT; Wu MH; Lin CY; Chen PC
    PLoS One; 2015; 10(10):e0137772. PubMed ID: 26452153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties.
    Nasiri-Amiri F; Ramezani Tehrani F; Simbar M; Montazeri A; Mohammadpour RA
    Qual Life Res; 2016 Jul; 25(7):1791-801. PubMed ID: 26814480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Chinese version of the modified polycystic ovary syndrome health-related quality-of-life questionnaire.
    Luo YY; Xu XL; Li XB
    Health Qual Life Outcomes; 2020 May; 18(1):131. PubMed ID: 32393360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iranian version of modified polycystic ovary syndrome health-related quality of Life questionnaire: Discriminant and convergent validity.
    Bazarganipour F; Ziaei S; Montazeri A; Foroozanfard F; Faghihzadeh S
    Iran J Reprod Med; 2013 Sep; 11(9):753-60. PubMed ID: 24639816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The translation and validation of the Arabic Version of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (AR-PCOSQ).
    Alghadeer S; Algarawi A; Abu-Rkybah F; Alshebly MM; Alruthia Y
    BMC Womens Health; 2020 Oct; 20(1):244. PubMed ID: 33121466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents' polycystic ovary syndrome health-related quality of life questionnaire (APQ-20): development and psychometric properties.
    Saei Ghare Naz M; Ozgoli G; Ahmadi F; Alavi Majd H; Aflatounian A; Ramezani Tehrani F
    Eur J Pediatr; 2023 May; 182(5):2393-2407. PubMed ID: 36907946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): a psychometric study with the Serbian version.
    Stevanovic D; Bozic-Antic I; Stanojlovic O; Vojnovic Milutinovic D; Bjekic-Macut J; Jancic J; Macut D
    Women Health; 2019 Oct; 59(9):1015-1025. PubMed ID: 30870132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach.
    Bazarganipour F; Ziaei S; Montazeri A; Foroozanfard F; Kazemnejad A; Faghihzadeh S
    Fertil Steril; 2013 Nov; 100(5):1389-96. PubMed ID: 23891270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.
    Cinar N; Harmanci A; Demir B; Yildiz BO
    Hum Reprod; 2012 Jun; 27(6):1840-5. PubMed ID: 22473394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality-of-life questionnaire for women with polycystic ovary syndrome: a Chinese translation and validation study.
    Chung J; Kwan A; Kwok J; Chan S
    BJOG; 2016 Sep; 123(10):1638-45. PubMed ID: 27412270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.
    Guyatt G; Weaver B; Cronin L; Dooley JA; Azziz R
    J Clin Epidemiol; 2004 Dec; 57(12):1279-87. PubMed ID: 15617954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.
    Gholamrezaei A; Zolfaghari B; Farajzadegan Z; Nemati K; Daghaghzadeh H; Tavakkoli H; Emami MH
    Acta Med Iran; 2011; 49(6):390-5. PubMed ID: 21874644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decisional Balance Inventory (DBI) Adolescent Form for Smoking: Psychometric Properties of the Persian Version.
    Khazaee-Pool M; Pashaei T; Ponnet K; Jafari F; Alizadeh R
    BMC Public Health; 2017 May; 17(1):507. PubMed ID: 28545471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 147.